Could lowering immune drugs save kidney transplants during ICU crises?

NCT ID NCT06881927

First seen Nov 18, 2025 · Last updated May 08, 2026 · Updated 23 times

Summary

This study looks at whether reducing immunosuppressive medications can help kidney transplant patients recover from life-threatening infections in the intensive care unit. About 212 adult kidney transplant recipients who are admitted to the ICU with septic shock or severe breathing failure will be randomly assigned to either reduce their immune drugs or continue standard care. The goal is to see if this approach improves organ function without increasing the risk of transplant rejection.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.